M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Abbott agrees to acquire Facet Biotech for USD450m
Pharmaceuticals and medical products supplier Abbott Laboratories (NYSE:ABT) said on Tuesday that has signed a definitive agreement to acquire biotechnology company Facet Biotech Corp (NASDAQ:FACT).Under the terms of the deal Abbott will pay USD27 per share. The company said that the net...
If you want to view the full text, you must first purchase archive credits.
Return to Archives
New Search